Logo do repositório
 

Safety Assessment of Potentially Inappropriate Medications (PIM) use in Older People and the Factors Associated with Hospital Admission

dc.contributor.authorVarallo, Fabiana Rossi [UNESP]
dc.contributor.authorCapucho, Helaine Carneiro
dc.contributor.authorPlaneta, Cleopatra da Silva [UNESP]
dc.contributor.authorMastroianni, Patricia de Carvalho [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2014-05-20T13:25:35Z
dc.date.available2014-05-20T13:25:35Z
dc.date.issued2011-01-01
dc.description.abstractPurpose: Potentially Inappropriate Medications (PIM) use in elderly people may be responsible for the development of Adverse Drug Reaction (ADR) which, when severe, leads to hospital admissions. Objectives: to estimate the prevalence of elderly who had used PIM before being admitted to hospital and to identify the risk factors and the hospitalizations related to ADR arising from PIM. Methods: A descriptive and cross-sectional study was performed in the internal medicine ward of a teaching hospital (Brazil), in 2008. With the aid of a validated form, patients aged >= 60 years, with length of hospital stay >= 24 hours, were interviewed about drugs taken prior to the hospital admission and the complaints/reasons for hospitalization. Results: 19.1% (59/308) of older patients had taken PIM before hospital admission and in 4.9%; there were a causal relation between the PIM taken and the complaint reported. PIM responsible for admissions were: amiodarone, amitriptyline, cimetidine, clonidine, diazepam, digoxin, estrogen, fluoxetine, lorazepam, short-acting nifedipine and propranolol. 47.0% of the clinical manifestations of PIM-related ADR were: dizziness, fatigue, digoxin toxicity and erythema. Only polypharmacy was detected as a risk factor for the occurrence of ADR of PIM (p = 0.02). Conclusion: PIM use in elderly people is not a risk factor for ADR-related hospital admission. Probably, severe ADR, which lead to hospitalizations of older people, can be explained by idiosyncratic response or the predisposition of these patients to develop adverse drug events, whether or not drugs are classed as PIM.en
dc.description.affiliationUniv Estadual Paulista, Sch Pharmaceut Sci, Araraquara, SP, Brazil
dc.description.affiliationUniv São Paulo Ribeirao Preto, Risk Management Clin Hosp Ribeirao Preto, São Paulo, Brazil
dc.description.affiliationUnespUniv Estadual Paulista, Sch Pharmaceut Sci, Araraquara, SP, Brazil
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.format.extent283-290
dc.identifierhttp://ejournals.library.ualberta.ca/index.php/JPPS/article/view/9795/8379
dc.identifier.citationJournal of Pharmacy and Pharmaceutical Sciences. Edmonton: Canadian Soc Pharmaceutical Sciences, v. 14, n. 2, p. 283-290, 2011.
dc.identifier.fileWOS000295160000012.pdf
dc.identifier.issn1482-1826
dc.identifier.lattes2514762545280942
dc.identifier.lattes4160558780902988
dc.identifier.orcid0000-0001-8467-7278
dc.identifier.orcid0000-0002-1378-6327
dc.identifier.urihttp://hdl.handle.net/11449/8125
dc.identifier.wosWOS:000295160000012
dc.language.isoeng
dc.publisherCanadian Soc Pharmaceutical Sciences
dc.relation.ispartofJournal of Pharmacy and Pharmaceutical Sciences
dc.relation.ispartofjcr2.333
dc.relation.ispartofsjr0,574
dc.rights.accessRightsAcesso abertopt
dc.sourceWeb of Science
dc.titleSafety Assessment of Potentially Inappropriate Medications (PIM) use in Older People and the Factors Associated with Hospital Admissionen
dc.typeArtigopt
dcterms.licensehttp://ejournals.library.ualberta.ca/index.php/JPPS/about/submissions#copyrightNotice
dcterms.rightsHolderCanadian Soc Pharmaceutical Sciences
dspace.entity.typePublication
relation.isDepartmentOfPublicatione214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isDepartmentOfPublication.latestForDiscoverye214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.author.lattes4160558780902988[4]
unesp.author.lattes2514762545280942[3]
unesp.author.orcid0000-0001-8467-7278[4]
unesp.author.orcid0000-0002-1378-6327[3]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.departmentFármacos e Medicamentos - FCFpt
unesp.departmentPrincípios Ativos Naturais e Toxicologia - FCFpt

Arquivos

Pacote original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
WOS000295160000012.pdf
Tamanho:
292.29 KB
Formato:
Adobe Portable Document Format

Licença do pacote

Agora exibindo 1 - 2 de 2
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: